1. Dong, Yeqing, Huang, Yongsheng, Fan, Chengyan, Wang, Dong, Zheng, Zhi. 2021. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma. In Cell death & disease, 12, 444. doi:10.1038/s41419-021-03731-7. https://pubmed.ncbi.nlm.nih.gov/33947839/
2. Zhao, Jingyuan, Liu, Jinnan, Liu, Sichu, Yuan, Hong, Li, Shuai. 2023. GIPC2 is a tumor suppressor gene for acute myeloid leukemia and induces apoptosis of leukemia cells by regulating the PI3K/AKT pathway. In Epigenomics, 15, 369-383. doi:10.2217/epi-2023-0027. https://pubmed.ncbi.nlm.nih.gov/37212125/
3. Katoh, Masaru. . GIPC gene family (Review). In International journal of molecular medicine, 9, 585-9. doi:. https://pubmed.ncbi.nlm.nih.gov/12011974/
4. Kirikoshi, Hiroyuki, Katoh, Masaru. . Molecular cloning and characterization of human GIPC2, a novel gene homologous to human GIPC1 and Xenopus Kermit. In International journal of oncology, 20, 571-6. doi:. https://pubmed.ncbi.nlm.nih.gov/11836570/
5. Saitoh, Tetsuroh, Mine, Tetsuya, Katoh, Masaru. . Molecular cloning and characterization of human GIPC3, a novel gene homologous to human GIPC1 and GIPC2. In International journal of oncology, 20, 577-82. doi:. https://pubmed.ncbi.nlm.nih.gov/11836571/
6. Kang, Min, Su, Zhaoran. 2023. Increased expression of GIPC2 in colon adenocarcinoma is associated with a favorable prognosis and high levels of immune cell infiltration. In Oncology reports, 49, . doi:10.3892/or.2023.8503. https://pubmed.ncbi.nlm.nih.gov/36799193/
智鼠故事 
